Monash IVF Group (MVF) H2 2025 earnings summary

Executive summary

• Underlying NPAT for FY2025 was AUD 27.4 million, aligning with guidance despite challenging market conditions and industry activity declines.

• Revenue increased 6.7% year-over-year to AUD 271.9 million, mainly due to price increases, with underlying EBITDA up 5.6% to AUD 66.3 million and margins steady at 24.4%.

• Market share declined by 70 basis points, primarily in Victoria and Queensland, as stimulated cycles fell 5% and new patient registrations dropped 7%.

• Succession planning ensured leadership stability; an independent review into clinic incidents was completed and recommendations are being implemented.

• No final dividend declared for FY25 due to second-half earnings and cash flow considerations; board intends to resume dividends in FY26 if guidance is met.

Financial highlights

• Statutory NPAT was AUD 25.7 million, rebounding from a prior year loss of AUD 5.9 million impacted by a class action settlement.

• Revenue increased from AUD 255 million in FY24 to AUD 272 million in FY25, with domestic IVF contributing AUD 6.5 million and international business AUD 2.1 million.

• Operating cash flow conversion (excluding class action payments) was 86%, down from 103% last year, mainly due to timing of creditor payments.

• CapEx was AUD 14.5 million (5.3% of revenue), focused on new facilities, lab upgrades, and IT.

• Free cash flow was negative at -AUD 4.5 million, down from AUD 13.7 million in FY24.

Outlook and guidance

• FY2026 underlying NPAT is expected between AUD 20 million and AUD 23 million, reflecting a 10% decline in new patient registrations and deferred price increases.

• Management anticipates mid-single-digit growth resuming from FY2027, with FY2026 serving as a reset base.

• Board expects to resume dividends in FY26 if guidance is achieved.

• Operating cash conversion is expected to return to 90%-100% in FY26, and leverage ratio to remain flat at 1.7x.

• Long-term growth expected from genetics, donor, and egg freezing services; industry cycles projected to grow 2-3% p.a.